TCF4 and melanoma: Similarly, Pozniak and colleagues showed that overexpression of TCF4 leads to decreases in TNF-α and T cell activation and suppression of TCF4 elicits inflammation, including increases in IFNs, thereby increasing the sensitivity of immune checkpoint inhibitors used to treat melanoma (51).